Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate

Cited by papers we hold 14

• An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques · 2020
  No notice
• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice · 2020
  No notice
• The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2 · 2020
  No notice
• COVID-19: Coronavirus Vaccine Development Updates · 2020
  No notice
• Vaccines for COVID-19 · 2020
  No notice
• From SARS to MERS, Thrusting Coronaviruses into the Spotlight · 2019
  No notice
• Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus · 2019
  No notice
• MERS-CoV: Understanding the Latest Human Coronavirus Threat · 2018
  No notice
• MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection · 2018
  No notice
• MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis · 2017
  No notice
• Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation · 2016
  No notice
• Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses · 2016
  No notice
• MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques · 2016
  No notice
• Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.